100 episodes

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Psychopharmacology and Psychiatry Updates Psychopharmacology Institute

    • Health & Fitness
    • 3.7 • 3 Ratings

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

    SGAs in Youth With Bipolar Depression

    SGAs in Youth With Bipolar Depression

    What are the safest and most effective medications for depression in youth with bipolar disorder? In this episode, we compare the response rates of quetiapine, olanzapine, and lurasidone for bipolar depression in youth. This episode also explains the differences in metabolic side effects and discusses the limitations of this study. 
    Faculty: David Rosenberg, M.D.
    Host: Richard Seeber, M.D.
    Learn more about our memberships here Earn 0.5 CMEs: Smart Take Vol. 01 Efficacy and Safety of SGAs in Youth With Bipolar Depression

    • 11 min
    Pharmacologic Treatments for BPSD

    Pharmacologic Treatments for BPSD

    This episode discusses the pharmacologic treatments for BPSD, including the indications for using psychotropic medications as first-line treatment. It also explains when medications are ineffective and when to use them as a temporary measure.
    Faculty: Lauren Gerlach, D.O.
    Host: Richard Seeber, M.D.
    Learn more about our memberships here Earn 1 CME: Management of Behavioral and Psychological Symptoms of Dementia Overview of Pharmacologic Treatment for BPSD

    • 7 min
    Association Between FIASMA Psychotropics and COVID-19

    Association Between FIASMA Psychotropics and COVID-19

    What are FIASMA psychotropics? What do they have to do with COVID-19? In this episode, we discuss a recent study that compared rates of severe illness among patients who, when admitted for COVID-19, were or were not taking a FIASMA—a functional inhibitor of acid sphingomyelinase activity.
    Faculty: Jim Phelps, M.D.
    Host: Richard Seeber, M.D.
    Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 40 Association Between FIASMA Psychotropic Medications and Reduced Risk of Intubation or Death in Individuals With Psychiatric Disorders Hospitalized for Severe COVID-19: An Observational Multicenter Study

    • 10 min
    Treatment Approaches for BPSD

    Treatment Approaches for BPSD

    Are antipsychotics the answer to the chaos of dementia? In this episode, we discuss the pharmacologic and nonpharmacologic treatment approaches to address BPSD, including the risks of using antipsychotics and the causes of death related to their use. 
    Faculty: Lauren Gerlach, D.O. 
    Host: Richard Seeber, M.D.
    Learn more about our memberships here Earn 1 CME: Management of Behavioral and Psychological Symptoms of Dementia Pharmacologic and Nonpharmacologic Treatment Approaches

    • 8 min
    Brexpiprazole for Borderline Personality Disorder

    Brexpiprazole for Borderline Personality Disorder

    In this episode, we discuss a recent RCT on using brexpiprazole to treat borderline personality disorder. Is it safe and effective? Could brexpiprazole be the magic bullet we were waiting for? 
    Faculty: Jim Phelps, M.D. 
    Host: Richard Seeber, M.D.
    Learn more about our memberships here Earn 0.5 CMEs: Quick Take Vol. 40 A Double-Blind Placebo-Controlled Study of Brexpiprazole for the Treatment of Borderline Personality Disorder

    • 8 min
    Patient, Caregiver, and Environmental Factors Underlying BPSD

    Patient, Caregiver, and Environmental Factors Underlying BPSD

    This episode discusses the patient factors underlying BPSD, such as neurodegeneration, acute medical issues, medication changes, pain, and psychiatric diagnoses. It also explains caregiver and environmental factors and the concept of the “broken brain.” 
    Faculty: Lauren Gerlach, D.O. 
    Host: Richard Seeber, M.D.
    Learn more about our memberships here Earn 1 CME: Management of Behavioral and Psychological Symptoms of Dementia Understanding Patient, Caregiver, and Enviromental Factors

    • 11 min

Customer Reviews

3.7 out of 5
3 Ratings

3 Ratings

Top Podcasts In Health & Fitness

Scicomm Media
Jay Shetty
IVM Podcasts
Dr Rangan Chatterjee: GP & Author
Rob Dial and Kast Media
Radio America

You Might Also Like

Pocket Psychiatry: A Carlat Podcast
Neuroscience Education Institute
PsychEd
David Puder, M.D.
Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist
American Journal of Psychiatry